Importer of Controlled Substances; Notice of Registration; Chattem Chemicals, Inc., 5498-5499 [2013-01530]
Download as PDF
<![CDATA[
5498
Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; R & D Systems,
Inc.
By Notice dated August 17, 2012, and
published in the Federal Register on
August 20, 2012, 77 FR 50162, R & D
Systems, Inc., 614 McKinley Place NE.,
Minneapolis, Minnesota 55413, made
application to the Drug Enforcement
Administration (DEA) to be registered as
an importer of the following basic
classes of controlled substances:
Drug
Schedule
mstockstill on DSK4VPTVN1PROD with
1-Pentyl-3-(1-naphthoyl)indole
(7118).
5-(1,1-Dimethylheptyl)-2-[(1R,3S)3- hydroxycyclohexyl]- phenol
(7297).
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
4-Bromo-2,5dimethoxyamphetamine (7391).
3,4Methylenedioxymethamphetamine (7405).
Dimethyltryptamine (7435) ...........
Amphetamine (1100) ....................
Methylphenidate (1724) ................
Phencyclidine (7471) ....................
Cocaine (9041) .............................
Oxycodone (9143) ........................
Thebaine (9333) ...........................
Fentanyl (9801) ............................
I
18:39 Jan 24, 2013
I
I
I
I
[FR Doc. 2013–01554 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances,
Notice of Registration, Myoderm
Drug
I
II
II
II
II
II
II
II
Jkt 229001
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
By Notice dated June 28, 2012, and
published in the Federal Register on
July 5, 2012, 77 FR 39741, Myoderm, 48
East Main Street, Norristown,
Pennsylvania 19401, made application
to the Drug Enforcement Administration
(DEA) to be registered as an importer of
the following basic classes of controlled
substances:
I
The company plans to import the
listed controlled substances in dosage
form to distribute to researchers.
In reference to drug codes 7360 and
7370, the company plans to import a
synthetic cannabidiol and a synthetic
Tetrahydrocannabinol. No other activity
for this drug code is authorized for this
registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
R & D Systems, Inc., to import the basic
classes of controlled substances is
consistent with the public interest, and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated R & D
Systems, Inc., to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
VerDate Mar<15>2010
with 21 CFR § 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Schedule
Amphetamine (1100) ....................
Lisdexamfetamine (1205) .............
Methylphenidate (1724) ................
Pentobarbital (2270) .....................
Nabilone (7379) ............................
Codeine (9050) .............................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Levomethorphan (9210) ...............
Meperidine (9230) ........................
Methadone (9250) ........................
Methadone intermediate (9254) ...
Morphine (9300) ...........................
Oxymorphone (9652) ...................
Fentanyl (9801) ............................
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to import the
listed controlled substances in finished
dosage form for clinical trials, and
research.
The import of the above listed basic
classes of controlled substances is
granted only for analytical testing and
clinical trials. This authorization does
not extend to the import of a finished
FDA approved or non-approved dosage
form for commercial distribution in the
United States.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a),
and determined that the registration of
Myoderm, to import the basic classes of
controlled substances is consistent with
the public interest, and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971, at this time. DEA
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
has investigated Myoderm, to ensure
that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–01540 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration; Chattem
Chemicals, Inc.
By Notice dated June 28, 2012, and
published in the Federal Register on
July 6, 2012, 77 FR 40086, Chattem
Chemicals, Inc., 3801 St. Elmo Avenue,
Chattanooga, Tennessee 37409, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the
following basic classes of controlled
substances:
Drug
Methamphetamine (1105) ............
4-Anilino-N-phenethyl-4-piperidine
(8333).
Phenylacetone (8501) ..................
Opium, raw (9600) .......................
Poppy Straw Concentrate (9670)
Tapentadol (9780) ........................
Schedule
II
II
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substances
for sale to its customers.
The company plans to import an
intermediate form of Tapentadol (9780),
to bulk manufacture Tapentadol for
distribution to its customers.
Comments and requests for hearing on
applications to import narcotic raw
material are not appropriate, 72 FR
3417(2007).
Regarding all other basic classes of
controlled substances, no comments or
objections have been received. DEA has
considered the factors in 21 U.S.C.
823(a) and 952(a), and determined that
E:\FR\FM\25JAN1.SGM
25JAN1
Federal Register / Vol. 78, No. 17 / Friday, January 25, 2013 / Notices
the registration of Chattem Chemicals,
Inc., to import the basic classes of
controlled substances is consistent with
the public interest, and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. DEA has
investigated Chattem Chemicals, Inc., to
ensure that the company’s rgistration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the above named
company is granted registration as an
importer of the basic classes of
controlled substances listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Drug
Schedule
2C-N (7521) ..................................
2C-P (7524) ..................................
2C-T-4 (7532) ...............................
AM-694 (7694) .............................
Metazocine (9240) ........................
The company plans to manufacture
the listed controlled substances for
distribution to their research and
forensic customers conducting drug
testing and analysis.
Any other such applicant, and any
person who is presently registered with
DEA to manufacture such substances,
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 8701 Morrissette Drive,
Springfield, Virginia 22152; and must be
filed no later than March 26, 2013.
Dated: January 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–01530 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[FR Doc. 2013–01556 Filed 1–24–13; 8:45 am]
Drug Enforcement Administration
BILLING CODE 4410–09–P
Manufacturer of Controlled
Substances; Notice of Application;
Cerilliant Corporation
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Pursuant to § 1301.33(a), Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on October 4, 2012,
Cerilliant Corporation, 811 Paloma
Drive, Suite A, Round Rock, Texas
78665–2402, made application to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
mstockstill on DSK4VPTVN1PROD with
I
I
I
I
II
Schedule
JWH-250 (6250) ...........................
SR-18 also known as RCS-8
(7008).
JWH-019 (7019) ...........................
JWH-081 (7081) ...........................
SR-19 also known as RCS-4
(7104).
JWH-122 (7122) ...........................
AM-2201 (7201) ...........................
JWH-203 (7203) ...........................
2C-T-2 (7385) ...............................
JWH-398 (7398) ...........................
N-Ethyl-1-phenylcyclohexylamine
(7455).
2C-D (7508) ..................................
2C-E (7509) ..................................
2C-H (7517) ..................................
2C-I (7518) ...................................
2C-C (7519) ..................................
VerDate Mar<15>2010
18:39 Jan 24, 2013
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
Jkt 229001
Manufacturer of Controlled
Substances, Notice of Registration;
Sigma Aldrich Research Biochemicals,
Inc.
By Notice dated September 20, 2012,
and published in the Federal Register
on October 2, 2012, 77 FR 60145, Sigma
Aldrich Research Biochemicals, Inc.,
1–3 Strathmore Road, Natick,
Massachusetts 01760–2447, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Schedule
4-Methyl-2,5dimethoxyamphetamine (7395).
Dimethyltryptamine (7435) ...........
I
I
The company plans to manufacture
reference standards.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Sigma Aldrich Research Biochemicals,
PO 00000
Frm 00093
Fmt 4703
Sfmt 4703
5499
Inc., to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research Biochemicals, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems; verification of the
company’s compliance with state and
local laws; and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: January 14, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2013–01588 Filed 1–24–13; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Johnson Matthey, Inc.
By Notice dated May 9, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30026, Johnson
Matthey, Inc., Custom Pharmaceuticals
Department, 2003 Nolte Drive, West
Deptford, New Jersey 08066–1742, made
application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Tapentadol (9780), a basic class of
controlled substance listed in schedule
II.
The company plans to manufacture
the listed controlled substance for sale
to its customers.
One comment objecting to the
granting of registration as a bulk
manufacturer of the basic class of
controlled substance listed to this
applicant was received. However, after
a thorough review of this matter, DEA
has concluded that the issues raised in
the comment and objection do not
warrant the denial of this application.
DEA has considered the factors in 21
U.S.C. 823(a) and determined that the
registration of Johnson Matthey, Inc., to
manufacture the listed basic class of
controlled substance is consistent with
the public interest at this time. DEA has
investigated Johnson Matthey, Inc., to
ensure that the company’s registration is
consistent with the public interest. The
E:\FR\FM\25JAN1.SGM
25JAN1
]]>Agencies
[Federal Register Volume 78, Number 17 (Friday, January 25, 2013)]
[Notices]
[Pages 5498-5499]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-01530]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration;
Chattem Chemicals, Inc.
By Notice dated June 28, 2012, and published in the Federal
Register on July 6, 2012, 77 FR 40086, Chattem Chemicals, Inc., 3801
St. Elmo Avenue, Chattanooga, Tennessee 37409, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methamphetamine (1105)..................... II
4-Anilino-N-phenethyl-4-piperidine (8333).. II
Phenylacetone (8501)....................... II
Opium, raw (9600).......................... II
Poppy Straw Concentrate (9670)............. II
Tapentadol (9780).......................... II
------------------------------------------------------------------------
The company plans to import the listed controlled substances to
manufacture bulk controlled substances for sale to its customers.
The company plans to import an intermediate form of Tapentadol
(9780), to bulk manufacture Tapentadol for distribution to its
customers.
Comments and requests for hearing on applications to import
narcotic raw material are not appropriate, 72 FR 3417(2007).
Regarding all other basic classes of controlled substances, no
comments or objections have been received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a), and determined that
[[Page 5499]]
the registration of Chattem Chemicals, Inc., to import the basic
classes of controlled substances is consistent with the public
interest, and with United States obligations under international
treaties, conventions, or protocols in effect on May 1, 1971. DEA has
investigated Chattem Chemicals, Inc., to ensure that the company's
rgistration is consistent with the public interest. The investigation
has included inspection and testing of the company's physical security
systems, verification of the company's compliance with state and local
laws, and a review of the company's background and history.
Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in
accordance with 21 CFR 1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: January 15, 2013.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2013-01530 Filed 1-24-13; 8:45 am]
BILLING CODE 4410-09-P
